Article info

PDF

A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study

Authors

  1. Correspondence to Dr Hiroshi Ishii; hiishii{at}shikoku-cc.go.jp
View Full Text

Citation

Ishii H, Yamashita N, Ueno M, et al
A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study

Publication history

  • Received November 7, 2017
  • Revised January 24, 2018
  • Accepted January 24, 2018
  • First published February 11, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.